single nucleotide variant | NM_058216.3(RAD51C):c.404G>A (p.Cys135Tyr) | RAD51C | Pathogenic/Likely pathogenic | 17 | 56772550 | 56772550 | G | A | criteria provided, multiple submitters, no conflicts | ClinGen:CA8677207 |
single nucleotide variant | NM_058216.3(RAD51C):c.705+1G>A | RAD51C | Likely pathogenic | 17 | 56780691 | 56780691 | G | A | criteria provided, multiple submitters, no conflicts | ClinGen:CA10580748 |
single nucleotide variant | NM_058216.3(RAD51C):c.837+1G>A | RAD51C | Pathogenic | 17 | 56787352 | 56787352 | G | A | criteria provided, multiple submitters, no conflicts | ClinGen:CA8677333,OMIM:602774.0008 |
Deletion | NM_058216.3(RAD51C):c.905-2del | RAD51C | Pathogenic/Likely pathogenic | 17 | 56801399 | 56801399 | CA | C | criteria provided, multiple submitters, no conflicts | ClinGen:CA10580755 |
single nucleotide variant | NM_058216.3(RAD51C):c.914G>A (p.Trp305Ter) | RAD51C | Pathogenic/Likely pathogenic | 17 | 56801410 | 56801410 | G | A | criteria provided, multiple submitters, no conflicts | ClinGen:CA10580757 |
single nucleotide variant | NM_058216.3(RAD51C):c.1005C>A (p.Cys335Ter) | RAD51C | Likely pathogenic | 17 | 56809884 | 56809884 | C | A | criteria provided, multiple submitters, no conflicts | ClinGen:CA8677385 |
Deletion | NM_000059.4(BRCA2):c.160_161del (p.Asn54fs) | BRCA2 | Pathogenic | 13 | 32893303 | 32893304 | TAA | T | reviewed by expert panel | ClinGen:CA10581584 |
single nucleotide variant | NM_000059.4(BRCA2):c.682-2A>G | BRCA2 | Pathogenic | 13 | 32905054 | 32905054 | A | G | reviewed by expert panel | ClinGen:CA10581585 |
Deletion | NM_000059.4(BRCA2):c.1906del (p.Ser636fs) | BRCA2 | Pathogenic | 13 | 32907520 | 32907520 | AT | A | reviewed by expert panel | ClinGen:CA10581586 |
Indel | NM_000059.3(BRCA2):c.4391_4393delinsTT (p.Ser1464fs) | BRCA2 | Pathogenic | 13 | 32912883 | 32912885 | CTG | TT | reviewed by expert panel | ClinGen:CA10581587 |